Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining ß-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.

Usui, Ryota; Sakuramachi, Yui; Seino, Yusuke; Murotani, Kenta; Kuwata, Hitoshi; Tatsuoka, Hisato; Hamamoto, Yoshiyuki; Kurose, Takeshi; Seino, Yutaka; Yabe, Daisuke

Usui, Ryota; Sakuramachi, Yui; Seino, Yusuke; Murotani, Kenta; Kuwata, Hitoshi; Tatsuoka, Hisato; Hamamoto, Yoshiyuki; Kurose, Takeshi; Seino, Yutaka; Yabe, Daisuke.

Afiliação

Usui R; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
Sakuramachi Y; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
Seino Y; Departments of Endocrinology and Diabetes Metabolic Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Murotani K; Division of Biostatistics, Clinical Research Center, Aichi Medical University Hospital, Nagakute, Japan.
Kuwata H; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
Tatsuoka H; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan.
Hamamoto Y; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
Kurose T; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan.
Seino Y; Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.
Yabe D; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan.

J Diabetes Investig ; 9(4): 822-830, 2018 Jul.

Article em En | MEDLINE | ID: mdl-29106046

Assuntos

Diabetes Mellitus Tipo 2/tratamento farmacológico; Hemoglobinas Glicadas/análise; Hipoglicemiantes/uso terapêutico; Células Secretoras de Insulina/metabolismo; Insulina/uso terapêutico; Liraglutida/uso terapêutico; Idoso; Povo Asiático; Peptídeo C/sangue; Quimioterapia Combinada; Feminino; Receptor do Peptídeo Semelhante ao Glucagon 1/agonistas; Humanos; Células Secretoras de Insulina/efeitos dos fármacos; Japão; Masculino; Pessoa de Meia-Idade; Curva ROC; Estudos Retrospectivos

Palavras-chave

Basal insulin; Liraglutide; ß-Cell function

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemoglobinas Glicadas / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Liraglutida / Hipoglicemiantes / Insulina Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Diabetes Investig Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google